FOLR1 and neoplasm: Similarly, secreted phosphoprotein 1 (SPP1) from CAFs diminishes the effectiveness of tyrosine kinase inhibitors (TKIs) by upregulating folate receptor alpha (FOLR1) in tumor cells [32,33].